BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26068031)

  • 1. Polymorphisms in NFKB1 and NFKBIA Genes Modulate the Risk of Developing Prostate Cancer among Han Chinese.
    Han X; Zhang JJ; Yao N; Wang G; Mei J; Li B; Li C; Wang ZA
    Med Sci Monit; 2015 Jun; 21():1707-15. PubMed ID: 26068031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China.
    Gao J; Xu HL; Gao S; Zhang W; Tan YT; Rothman N; Purdue M; Gao YT; Zheng W; Shu XO; Xiang YB
    BMJ Open; 2014 Feb; 4(2):e004427. PubMed ID: 24578542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    PLoS One; 2013; 8(12):e81999. PubMed ID: 24324738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.
    Lai HM; Li XM; Yang YN; Ma YT; Xu R; Pan S; Zhai H; Liu F; Chen BD; Zhao Q
    PLoS One; 2015; 10(6):e0129144. PubMed ID: 26075620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
    Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
    Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
    He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
    Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.
    Lu ZH; Gu XJ; Shi KZ; Li X; Chen DD; Chen L
    J Formos Med Assoc; 2016 Jan; 115(1):31-7. PubMed ID: 25659662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variations in Inflammatory Response Genes and Their Association with the Risk of Prostate Cancer.
    Cui X; Yan H; Ou TW; Jia CS; Wang Q; Xu JJ
    Biomed Res Int; 2015; 2015():674039. PubMed ID: 26788504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer.
    Lin CW; Hsieh YS; Hsin CH; Su CW; Lin CH; Wei LH; Yang SF; Chien MH
    PLoS One; 2012; 7(4):e35078. PubMed ID: 22509384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Behçet's disease.
    Yenmis G; Oner T; Cam C; Koc A; Kucuk OS; Yakicier MC; Dizman D; Kanigur Sultuybek G
    Scand J Immunol; 2015 Jan; 81(1):81-6. PubMed ID: 25367031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
    Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
    PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.
    Cheng CW; Su JL; Lin CW; Su CW; Shih CH; Yang SF; Chien MH
    PLoS One; 2013; 8(2):e56130. PubMed ID: 23457512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of -94 ATTG insertion/deletion NFkB1 and c.*126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson's Disease.
    Baltus THL; Morelli NR; de Farias CC; Trugilo KP; Okuyama NCM; de Oliveira KB; de Melo LB; Smaili SM; Barbosa DS
    Neurosci Lett; 2021 Jan; 740():135487. PubMed ID: 33161109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional haplotype of NFKB1 influence susceptibility to oral cancer: a population-based and in vitro study.
    Chen F; Liu F; Yan L; Lin L; Qiu Y; Wang J; Wu J; Bao X; Hu Z; Cai L; He B
    Cancer Med; 2018 May; 7(5):2211-2218. PubMed ID: 29635862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. -94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.
    Boccardi V; Rizzo MR; Marfella R; Papa M; Esposito A; Portoghese M; Paolisso G; Barbieri M
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):679-84. PubMed ID: 20304615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations.
    Gao J; Pfeifer D; He LJ; Qiao F; Zhang Z; Arbman G; Wang ZL; Jia CR; Carstensen J; Sun XF
    Scand J Gastroenterol; 2007 Mar; 42(3):345-50. PubMed ID: 17354114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer.
    Li D; Wu C; Cai Y; Liu B
    Tumour Biol; 2017 Jul; 39(7):1010428317717107. PubMed ID: 28670959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function.
    Coto E; Díaz-Corte C; Tranche S; Gómez J; Alonso B; Iglesias S; Reguero JR; López-Larrea C; Coto-Segura P
    Hum Immunol; 2018 Jun; 79(6):494-498. PubMed ID: 29601852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.